Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2791038413', 'doi': 'https://doi.org/10.1080/17474086.2018.1456332', 'title': 'Potential of BCL2 as a target for chronic lymphocytic leukemia treatment', 'display_name': 'Potential of BCL2 as a target for chronic lymphocytic leukemia treatment', 'publication_year': 2018, 'publication_date': '2018-03-29', 'ids': {'openalex': 'https://openalex.org/W2791038413', 'doi': 'https://doi.org/10.1080/17474086.2018.1456332', 'mag': '2791038413', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/29561706'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/17474086.2018.1456332', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S73682863', 'display_name': 'Expert Review of Hematology', 'issn_l': '1747-4094', 'issn': ['1747-4094', '1747-4086'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5026766394', 'display_name': 'Riccardo Moia', 'orcid': 'https://orcid.org/0000-0001-7393-1138'}, 'institutions': [{'id': 'https://openalex.org/I123338534', 'display_name': 'Università degli Studi del Piemonte Orientale “Amedeo Avogadro”', 'ror': 'https://ror.org/04387x656', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I123338534']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Riccardo Moia', 'raw_affiliation_strings': ['Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy', 'institution_ids': ['https://openalex.org/I123338534']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017631081', 'display_name': 'Fary Diop', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I123338534', 'display_name': 'Università degli Studi del Piemonte Orientale “Amedeo Avogadro”', 'ror': 'https://ror.org/04387x656', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I123338534']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Fary Diop', 'raw_affiliation_strings': ['Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy', 'institution_ids': ['https://openalex.org/I123338534']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054337894', 'display_name': 'Chiara Favini', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I123338534', 'display_name': 'Università degli Studi del Piemonte Orientale “Amedeo Avogadro”', 'ror': 'https://ror.org/04387x656', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I123338534']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Chiara Favini', 'raw_affiliation_strings': ['Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy', 'institution_ids': ['https://openalex.org/I123338534']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083238024', 'display_name': 'Ahad Ahmed Kodipad', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I123338534', 'display_name': 'Università degli Studi del Piemonte Orientale “Amedeo Avogadro”', 'ror': 'https://ror.org/04387x656', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I123338534']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Ahad Ahmed Kodipad', 'raw_affiliation_strings': ['Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy', 'institution_ids': ['https://openalex.org/I123338534']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5041745367', 'display_name': 'Gianluca Gaïdano', 'orcid': 'https://orcid.org/0000-0002-4681-0151'}, 'institutions': [{'id': 'https://openalex.org/I123338534', 'display_name': 'Università degli Studi del Piemonte Orientale “Amedeo Avogadro”', 'ror': 'https://ror.org/04387x656', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I123338534']}], 'countries': ['IT'], 'is_corresponding': True, 'raw_author_name': 'Gianluca Gaidano', 'raw_affiliation_strings': ['Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy'], 'affiliations': [{'raw_affiliation_string': 'Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy', 'institution_ids': ['https://openalex.org/I123338534']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5041745367'], 'corresponding_institution_ids': ['https://openalex.org/I123338534'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.231, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 16, 'citation_normalized_percentile': {'value': 0.394619, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '11', 'issue': '5', 'first_page': '391', 'last_page': '402'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10583', 'display_name': 'The p53 Signaling Network in Cancer Research', 'score': 0.9968, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10294', 'display_name': 'Molecular Mechanisms of Apoptosis and Cell Death', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/venetoclax', 'display_name': 'Venetoclax', 'score': 0.9980144}, {'id': 'https://openalex.org/keywords/cancer-therapy', 'display_name': 'Cancer Therapy', 'score': 0.502747}], 'concepts': [{'id': 'https://openalex.org/C2779675984', 'wikidata': 'https://www.wikidata.org/wiki/Q23671272', 'display_name': 'Venetoclax', 'level': 4, 'score': 0.9980144}, {'id': 'https://openalex.org/C2777938653', 'wikidata': 'https://www.wikidata.org/wiki/Q1088156', 'display_name': 'Chronic lymphocytic leukemia', 'level': 3, 'score': 0.75049114}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.66837674}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.47477198}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.36577943}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.35202557}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.33991408}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.32990152}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D019253', 'descriptor_name': 'Proto-Oncogene Proteins c-bcl-2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019086', 'descriptor_name': 'Bridged Bicyclo Compounds, Heterocyclic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D019253', 'descriptor_name': 'Proto-Oncogene Proteins c-bcl-2', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D019253', 'descriptor_name': 'Proto-Oncogene Proteins c-bcl-2', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D019253', 'descriptor_name': 'Proto-Oncogene Proteins c-bcl-2', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D012008', 'descriptor_name': 'Recurrence', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016159', 'descriptor_name': 'Tumor Suppressor Protein p53', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D016159', 'descriptor_name': 'Tumor Suppressor Protein p53', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D016159', 'descriptor_name': 'Tumor Suppressor Protein p53', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/17474086.2018.1456332', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S73682863', 'display_name': 'Expert Review of Hematology', 'issn_l': '1747-4094', 'issn': ['1747-4094', '1747-4086'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/29561706', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.82, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [{'funder': 'https://openalex.org/F4320321781', 'funder_display_name': 'Ministero della Salute', 'award_id': None}, {'funder': 'https://openalex.org/F4320321873', 'funder_display_name': 'Ministero dell’Istruzione, dell’Università e della Ricerca', 'award_id': 'PRIN 2015ZMRFEA_004'}, {'funder': 'https://openalex.org/F4320323054', 'funder_display_name': 'Associazione Italiana per la Ricerca sul Cancro', 'award_id': 'Progetto Ricerca Finalizzata (RF-2011-02349712)'}], 'datasets': [], 'versions': [], 'referenced_works_count': 66, 'referenced_works': ['https://openalex.org/W1196637763', 'https://openalex.org/W122353466', 'https://openalex.org/W1963571549', 'https://openalex.org/W1964617786', 'https://openalex.org/W1966035396', 'https://openalex.org/W1972091733', 'https://openalex.org/W1985563073', 'https://openalex.org/W1990924960', 'https://openalex.org/W1992045438', 'https://openalex.org/W1995443324', 'https://openalex.org/W1999128869', 'https://openalex.org/W2008898220', 'https://openalex.org/W2009183764', 'https://openalex.org/W2018077387', 'https://openalex.org/W2024216962', 'https://openalex.org/W2025128734', 'https://openalex.org/W2028959659', 'https://openalex.org/W2035918677', 'https://openalex.org/W2037980270', 'https://openalex.org/W2038067635', 'https://openalex.org/W2038683465', 'https://openalex.org/W2039640090', 'https://openalex.org/W2047115666', 'https://openalex.org/W2049372901', 'https://openalex.org/W2052853635', 'https://openalex.org/W2057473797', 'https://openalex.org/W2070692423', 'https://openalex.org/W2089082314', 'https://openalex.org/W2089298737', 'https://openalex.org/W2097290512', 'https://openalex.org/W2113278680', 'https://openalex.org/W2113895281', 'https://openalex.org/W2119683782', 'https://openalex.org/W2126322093', 'https://openalex.org/W2129087581', 'https://openalex.org/W2135314242', 'https://openalex.org/W2136272158', 'https://openalex.org/W2140773464', 'https://openalex.org/W2142099365', 'https://openalex.org/W2144701362', 'https://openalex.org/W2150048195', 'https://openalex.org/W2152256447', 'https://openalex.org/W2153923291', 'https://openalex.org/W2168632005', 'https://openalex.org/W2172242534', 'https://openalex.org/W2192121806', 'https://openalex.org/W2283026262', 'https://openalex.org/W2318933236', 'https://openalex.org/W2335061472', 'https://openalex.org/W2338693134', 'https://openalex.org/W2369297677', 'https://openalex.org/W2426446588', 'https://openalex.org/W2470301306', 'https://openalex.org/W2516709103', 'https://openalex.org/W2573476619', 'https://openalex.org/W2589238872', 'https://openalex.org/W2750813742', 'https://openalex.org/W2761167910', 'https://openalex.org/W2782297997', 'https://openalex.org/W2782454513', 'https://openalex.org/W2784863453', 'https://openalex.org/W2785489778', 'https://openalex.org/W2904446924', 'https://openalex.org/W2907684934', 'https://openalex.org/W2917576605', 'https://openalex.org/W2920910551'], 'related_works': ['https://openalex.org/W579273576', 'https://openalex.org/W4323807861', 'https://openalex.org/W4234339317', 'https://openalex.org/W4232967614', 'https://openalex.org/W4225091882', 'https://openalex.org/W3080900421', 'https://openalex.org/W2883592788', 'https://openalex.org/W2791038413', 'https://openalex.org/W2753631200', 'https://openalex.org/W2418031697'], 'abstract_inverted_index': {'Introduction:': [0], 'Chronic': [1], 'lymphocytic': [2], 'leukemia': [3], '(CLL)': [4], 'is': [5, 13, 185], 'a': [6, 14, 20, 76, 91, 132, 181, 186], 'highly': [7], 'heterogeneous': [8], 'disease.': [9], 'Deregulation': [10], 'of': [11, 86, 99, 101, 129, 189], 'apoptosis': [12, 87], 'major': [15, 133, 187], 'pathogenetic': [16], 'feature,': [17], 'and': [18, 32, 74, 94, 138], 'represents': [19, 131], 'therapeutic': [21], 'target.': [22], 'TP53': [23, 58, 164, 183], 'disrupted': [24], 'patients': [25, 31, 162], 'are': [26, 33], 'categorized': [27], 'as': [28], 'high': [29, 51], 'risk': [30], 'treated': [34], 'with': [35, 57, 67, 75, 96, 122, 153, 163], 'novel': [36], 'target': [37], 'therapies.': [38], 'Among': [39], 'these': [40], 'new': [41, 140], 'drugs,': [42], 'venetoclax,': [43], 'an': [44], 'orally': [45], 'bioavailable': [46], 'BCL2': [47, 102], 'inhibitor,': [48], 'has': [49, 61, 157], 'shown': [50], 'efficacy': [52], 'also': [53, 62, 160], 'in': [54, 65, 88, 104, 119, 124, 135, 161], 'relapsed/refractory': [55], 'CLL': [56, 89, 136, 177], 'disruption.': [59, 165], 'Venetoclax': [60, 156], 'been': [63], 'tested': [64], 'combination': [66], 'other': [68, 154], 'drugs': [69], 'without': [70], 'compromising': [71], 'venetoclax': [72, 123, 130, 152, 175], 'dose': [73], 'good': [77], 'safety': [78], 'profile.Areas': [79], 'covered:': [80], 'This': [81], 'article': [82], 'covers': [83], 'the': [84, 97, 111, 116, 145, 171], 'biology': [85], 'from': [90], 'translational': [92], 'viewpoint': [93], 'deals': [95], 'mode': [98], 'action': [100], 'inhibitors,': [103], 'particular': [105], 'venetoclax.': [106], 'On': [107], 'this': [108], 'biological': [109], 'rationale,': [110], 'review': [112], 'then': [113], 'focuses': [114], 'on': [115], 'results': [117, 146, 167], 'obtained': [118, 147], 'clinical': [120], 'trials': [121], 'CLL.Expert': [125], 'commentary:': [126], 'The': [127], 'availability': [128], 'advance': [134], 'treatment': [137], 'offers': [139], 'opportunities': [141], 'to': [142, 191], 'further': [143], 'improve': [144], 'until': [148], 'now': [149], 'by': [150, 173], 'combining': [151], 'agents.': [155, 194], 'achieved': [158], 'responses': [159], 'These': [166], 'strongly': [168], 'suggest': [169], 'that': [170, 184], 'mechanism': [172], 'which': [174], 'kills': [176], 'cells': [178], 'might': [179], 'overcome': [180], 'dysfunctional': [182], 'hallmark': [188], 'chemorefractoriness': [190], 'conventional': [192], 'antineoplastic': [193]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2791038413', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 7}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 4}], 'updated_date': '2024-08-22T16:39:49.411761', 'created_date': '2018-03-29'}